FDA Approval Drives Sarepta Therapeutics (SRPT) Shares Higher
Fahim Awan
June 21, 2024
After securing an extended regulatory approval, Sarepta Therapeutics, Inc. (NASDAQ: SRPT) witnessed a significant rise in its stock value on the US charts today. As